Robotic-assisted surgery in gynecologic oncology: A Society of Gynecologic Oncology consensus statement
Pedro T. Ramírez(Houston Methodist), Stephanie Yap(Southeastern Medical Oncology Center), Robert W. Holloway(Florida Hospital Cancer Institute), Javier F. Magrina(Mayo Clinic in Arizona), John F. Boggess(University of Kentucky), Pamela T. Soliman(The University of Texas MD Anderson Cancer Center), Ginger J. Gardner(Memorial Sloan Kettering Cancer Center), William M. Burke(Stony Brook University Hospital), Laura J. Havrilesky(Duke University), M. Patrick Lowe(Advocate Christ Medical Center), David H. Moore(Gynecologic Oncology Group), Sarah Adams(California University of Pennsylvania)
Cited by 97
Related Papers
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
|The Lancet Oncology|2017|929
Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
|Journal of Clinical Oncology|2004|644
A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy
|American Journal of Obstetrics and Gynecology|2008|458